Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial.
about
Repurposing drugs for the treatment and control of helminth infectionsKilling filarial nematode parasites: role of treatment options and host immune responseAnti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasisComparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot TrialA review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasisPoint-of-Care Ultrasound Assessment of Tropical Infectious Diseases--A Review of Applications and Perspectives.Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindnessDevelopment and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.Developing a community-led SMS reporting tool for the rapid assessment of lymphatic filariasis morbidity burden: case studies from Malawi and Ghana.Changes in Antibody Levels during and following an Episode of Acute Adenolymphangitis (ADL) among Lymphedema Patients in Léogâne, HaitiMinocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.Self-Care for Management of Secondary Lymphedema: A Systematic Review.Measuring the physical and economic impact of filarial lymphoedema in Chikwawa district, Malawi: a case-control study.Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.Situational analysis of lymphatic filariasis morbidity in Ahanta West District of Ghana.Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration.Reporting of pre-enrolment screening with randomized clinical trials: A small item that could impact a big difference.Immunity in Filarial Infections: Lessons from Animal Models and Human Studies.A survival tree method for the analysis of discrete event times in clinical and epidemiological studies.Seventh meeting of the Global Alliance to Eliminate Lymphatic Filariasis: reaching the vision by scaling up, scaling down, and reaching outSingle nucleotide polymorphisms in the angiogenic and lymphangiogenic pathways are associated with lymphedema caused by Wuchereria bancrofti.Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis.Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.Use of a Novel Portable Three-Dimensional Imaging System to Measure Limb Volume and Circumference in Patients with Filarial Lymphedema.Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs.Far-infrared ray for treating chronic lower extremity lymphedema with dermatolymphangioadenitis: a postoperative complication of gynecological tumor resection.
P2860
Q26823355-98584909-368B-43E7-AA15-4032FECDA867Q28074470-670D5700-6D02-42EF-A95D-9FE53733CEA7Q28294770-C143AACE-0B20-479D-8614-460783D16114Q28468411-813767B9-B947-456D-BA2F-3D65B556FA7BQ28535358-A77A58C6-FCA8-4A5F-99D4-037034FF108DQ30366003-BCC22DD7-A702-4863-AFBC-7ABB544CC9CFQ35207455-46087B9A-BD62-4197-95CF-D6559DA129ECQ35297570-2DF552A5-F6C9-47D7-8AE7-DCD3360862BDQ35633597-8F838D3B-8199-4EB9-9AAC-DF9AF41B1892Q35817421-0F91C4FB-FCF1-484A-9C9F-96863C64EBADQ36708214-8D08277C-C5F0-4575-A816-CBEE18641299Q36983089-51EF91A6-64B8-4FAB-94A1-3F755F59088CQ37733874-555D7055-2CDC-4578-8531-30FCAC2F67D6Q38123552-03AAC70E-E663-4636-873C-5EF3E447EA58Q38941025-6496D26B-8669-40E6-9927-B7C581AD8B17Q38953815-5E959F2C-7A79-4CE1-A0B4-07E6101CD2E9Q38979133-C09ABC73-B297-4A4C-ACA6-66ACC01C4358Q39123905-E8740594-3601-44B3-8021-F7F6E9945B7EQ40551137-558396F8-8494-4B1B-A836-DEE9EC685E61Q42705771-050ECF82-B5E9-438E-A27E-2FC48047C64DQ44246688-8910CED4-4B17-4460-8B8B-32C236567F82Q44288385-486B7130-3E69-46CE-BDE0-B700AC7826ADQ47102855-8BF1B458-0E6B-4CE0-9C67-E0F9656C6D1AQ47344802-49D249DF-C267-46B7-A492-C918506D05F0Q47553077-9C6C8DB0-417F-4C41-A4E3-59AE12968377Q47564134-E4A20B5B-1DD7-4DF1-89FF-EA24EA6D0F0B
P2860
Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Doxycycline improves filarial ...... a randomized controlled trial.
@ast
Doxycycline improves filarial ...... a randomized controlled trial.
@en
type
label
Doxycycline improves filarial ...... a randomized controlled trial.
@ast
Doxycycline improves filarial ...... a randomized controlled trial.
@en
prefLabel
Doxycycline improves filarial ...... a randomized controlled trial.
@ast
Doxycycline improves filarial ...... a randomized controlled trial.
@en
P2093
P2860
P356
P1476
Doxycycline improves filarial ...... a randomized controlled trial
@en
P2093
Achim Hoerauf
Alexander Yaw Debrah
Aurea Belda-Domene
Linda Batsa
Ohene Adjei
Rolf Fimmers
Sabine Mand
Sabine Specht
Ute Klarmann
Yeboah Marfo-Debrekyei
P2860
P304
P356
10.1093/CID/CIS486
P407
P577
2012-05-18T00:00:00Z